CSTL1

 

Full name: cystatin like 1 Alias Symbol: dJ322G13.4|CTES1
Type: protein-coding gene Cytoband: 20p11.21
Entrez ID: 128817 HGNC ID: HGNC:15958 Ensembl Gene: ENSG00000125823 OMIM ID: 
Drug and gene relationship at DGIdb

 

Expression of CSTL1:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 CSTL1 128817 234803_at 0.2030 0.3210
GSE26886 CSTL1 128817 234803_at -0.0174 0.8701
GSE45670 CSTL1 128817 234803_at 0.1342 0.0967
GSE53622 CSTL1 128817 48238 -2.4043 0.0000
GSE53624 CSTL1 128817 48238 -2.2729 0.0000
GSE63941 CSTL1 128817 234803_at 0.2417 0.1220
GSE77861 CSTL1 128817 234803_at -0.1285 0.2401
GSE97050 CSTL1 128817 A_33_P3381087 -0.7052 0.2094
TCGA CSTL1 128817 RNAseq 2.8604 0.0009

Upregulated datasets: 1; Downregulated datasets: 2.  


 

Survival by CSTL1 expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of CSTL1:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 CSTL1 128817 13 1 16
GSE20123 CSTL1 128817 13 1 16
GSE43470 CSTL1 128817 12 1 30
GSE46452 CSTL1 128817 27 1 31
GSE47630 CSTL1 128817 17 4 19
GSE54993 CSTL1 128817 0 17 53
GSE54994 CSTL1 128817 26 2 25
GSE60625 CSTL1 128817 0 0 11
GSE74703 CSTL1 128817 10 1 25
GSE74704 CSTL1 128817 7 1 12
TCGA CSTL1 128817 43 10 43

Total number of gains: 168; Total number of losses: 39; Total Number of normals: 281.  


 

Somatic mutations of CSTL1:

 

Generating mutation plots.

 

Highly correlated genes for CSTL1:

 

Showing top 20/202 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
CSTL1OTOF0.904913303
CSTL1OR2Z10.898183303
CSTL1KRTAP20-10.887632303
CSTL1OR10G80.885524303
CSTL1FAM163B0.884846303
CSTL1UPB10.873204404
CSTL1MFSD2B0.861968303
CSTL1NCCRP10.847567303
CSTL1C19orf570.846207303
CSTL1ELN0.82815303
CSTL1OTOP30.813236303
CSTL1MUC220.812214303
CSTL1BARHL20.797809303
CSTL1KPRP0.797382303
CSTL1KRT830.793919303
CSTL1RNF1510.792953303
CSTL1TEN10.791293303
CSTL1TMPRSS11A0.789955303
CSTL1OR5AS10.785709303
CSTL1RNF2220.778543303

For details and further investigation, click here